{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T20:14:40Z","timestamp":1787948080022,"version":"build-2784847793"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ajog.2025.03.015","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T17:14:17Z","timestamp":1742318057000},"page":"25-39.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Reduced risk of cesarean delivery with oxytocin discontinuation in active labor: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"233","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1452-6519","authenticated-orcid":false,"given":"Julia","family":"Whitley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Burd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Doering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannie","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonina","family":"Frolova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandini","family":"Raghuraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2025.03.015_bib1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/NMC.0000000000000824","article-title":"Trends in labor induction in the United States, 1989 to 2020","volume":"47","author":"Simpson","year":"2022","journal-title":"MCN Am J Matern Child Nurs"},{"key":"10.1016\/j.ajog.2025.03.015_bib2","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/jmwh.12975","article-title":"Associations among intrapartum interventions and cesarean birth in low-risk nulliparous women with spontaneous onset of labor","volume":"65","author":"Iobst","year":"2020","journal-title":"J Midwifery Womens Health"},{"key":"10.1016\/j.ajog.2025.03.015_bib3","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ogc.2017.08.012","article-title":"Augmentation of labor: a review of oxytocin augmentation and active management of labor","volume":"44","author":"Kernberg","year":"2017","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.ajog.2025.03.015_bib4","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1055\/s-0038-1675642","article-title":"Assessing maternal and fetal risks associated with prolonged induction of labor","volume":"36","author":"Triebwasser","year":"2019","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2025.03.015_bib5","article-title":"High-dose versus low-dose oxytocin infusion regimens for induction of labour at term","volume":"2014","author":"Budden","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2025.03.015_bib6","doi-asserted-by":"crossref","first-page":"313.e1","DOI":"10.1016\/j.ajog.2006.11.035","article-title":"Elevated uterine activity increases the risk of fetal acidosis at birth","volume":"196","author":"Bakker","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.03.015_bib7","doi-asserted-by":"crossref","first-page":"34.e1","DOI":"10.1016\/j.ajog.2007.12.015","article-title":"Effects of oxytocin-induced uterine hyperstimulation during labor on fetal oxygen status and fetal heart rate patterns","volume":"199","author":"Simpson","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.03.015_bib8","article-title":"Continued versus discontinued oxytocin after the active phase of labor: an updated systematic review and meta-analysis","volume":"17","author":"Jiang","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2025.03.015_bib9","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2025.03.015_bib10","unstructured":"Covidence systematic review software, Veritas Health Innovation, Melbourne, Australia. Available at: www.covidence.org. Accessed February 20, 2024."},{"key":"10.1016\/j.ajog.2025.03.015_bib11","first-page":"38","article-title":"Effects of intermittent and continuous oxytocin infusion on outcomes of pregnancy","volume":"16","author":"Pazandeh","year":"2007","journal-title":"HAYAT\u2014J Fac Nurs Midwifery"},{"key":"10.1016\/j.ajog.2025.03.015_bib12","series-title":"Cochrane handbook for systematic reviews of interventions version 6.4","article-title":"Chapter 8: assessing risk of bias in a randomized trial","author":"Higgins","year":"2023"},{"key":"10.1016\/j.ajog.2025.03.015_bib13","series-title":"The GRADE handbook","author":"Sch\u00fcnemann","year":"2013"},{"key":"10.1016\/j.ajog.2025.03.015_bib14","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ijgo.14964","article-title":"Improving trustworthiness in research in women's health: a collective effort by OBGYN editors","volume":"163","author":"Berghella","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajog.2025.03.015_bib15","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range","volume":"27","author":"Luo","year":"2018","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.ajog.2025.03.015_bib16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ajog.2025.03.015_bib17","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1471-0528.2004.00096.x","article-title":"For how long should oxytocin be continued during induction of labour?","volume":"111","author":"Daniel-Spiegel","year":"2004","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2025.03.015_bib18","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1447-0756.2007.00659.x","article-title":"Prospective randomized study of oxytocin discontinuation after the active stage of labor is established","volume":"33","author":"Ustunyurt","year":"2007","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.ajog.2025.03.015_bib19","first-page":"100","article-title":"The comparative examination of the effect of two oxytocin administration methods of labor induction on labor duration stages","volume":"16","author":"Bahadoran","year":"2011","journal-title":"Iran J Nurs Midwifery Res"},{"key":"10.1016\/j.ajog.2025.03.015_bib20","first-page":"121","article-title":"Comparative study between continuous use of oxytocin infusion throughout the active phase of labor versus its discontinuation and its effect on the course of labor","volume":"79","author":"Rashwan","year":"2011","journal-title":"Med J Cairo Univ"},{"key":"10.1016\/j.ajog.2025.03.015_bib21","doi-asserted-by":"crossref","first-page":"471.e1-8","DOI":"10.1016\/j.ajog.2012.08.035","article-title":"Oxytocin discontinuation during active labor in women who undergo labor induction","volume":"207","author":"Diven","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.03.015_bib22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.11566\/cmoshmcj.v12i2.35","article-title":"A randomized clinical trial on the need of continuing oxytocin infusion in active phase of induced labour","volume":"12","author":"Begum","year":"2013","journal-title":"Chattagram Maa-O-Shishu Hosp Med College J"},{"key":"10.1016\/j.ajog.2025.03.015_bib23","doi-asserted-by":"crossref","first-page":"320","DOI":"10.5001\/omj.2015.66","article-title":"Stopping oxytocin in active labor rather than continuing it until delivery: a viable option for the induction of labor","volume":"30","author":"Chopra","year":"2015","journal-title":"Oman Med J"},{"key":"10.1016\/j.ajog.2025.03.015_bib24","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/14767058.2014.906573","article-title":"Effect of oxytocin discontinuation during the active phase of labor","volume":"28","author":"\u00d6zt\u00fcrk","year":"2015","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2025.03.015_bib25","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/1471-0528.13589","article-title":"Continuation versus discontinuation of oxytocin infusion during the active phase of labour: a randomised controlled trial","volume":"123","author":"Bor","year":"2016","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2025.03.015_bib26","first-page":"73","article-title":"Cesarean section rate in oxytocin infusion between continuous until delivery and discontinuation at active phase of labor: a randomized controlled study","volume":"24","author":"Chookijkul","year":"2016","journal-title":"Thai J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2025.03.015_bib27","doi-asserted-by":"crossref","first-page":"441","DOI":"10.4103\/mmj.mmj_652_17","article-title":"The outcome of induced labor after oxytocin infusion discontinuation in the active phase","volume":"32","author":"Eissa","year":"2019","journal-title":"Menoufia Med J"},{"key":"10.1016\/j.ajog.2025.03.015_bib28","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.14260\/jemds\/2019\/725","article-title":"Continuation versus discontinuation of oxytocin in active phase of labour: a randomised trial","volume":"8","author":"Mitra","year":"2019","journal-title":"J Evolution Med Dent Sci"},{"key":"10.1016\/j.ajog.2025.03.015_bib29","article-title":"CONDISOX trial group. Continued versus discontinued oxytocin stimulation in the active phase of labour (CONDISOX): double blind randomised controlled trial","volume":"373","author":"Boie","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2025.03.015_bib30","doi-asserted-by":"crossref","first-page":"299","DOI":"10.21608\/amj.2021.139723","article-title":"Continuation versus discontinuation of oxytocin infusion throughout the active phase of labor and its effect on the course of induced labor","volume":"50","author":"El-Hakem","year":"2021","journal-title":"Al-Azhar Med J"},{"key":"10.1016\/j.ajog.2025.03.015_bib31","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/S0140-6736(23)01803-2","article-title":"Impact of discontinuing oxytocin in active labour on neonatal morbidity: an open-label, multicentre, randomised trial","volume":"402","author":"Girault","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2025.03.015_bib32","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/humupd\/4.5.625","article-title":"Desensitization of oxytocin receptors in human myometrium","volume":"4","author":"Phaneuf","year":"1998","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ajog.2025.03.015_bib33","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1067\/mob.2003.22","article-title":"Oxytocin-induced desensitization of the oxytocin receptor","volume":"188","author":"Robinson","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.03.015_bib34","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2011-000514","article-title":"Oxytocin during labour and risk of severe postpartum haemorrhage: a population-based, cohort-nested case-control study","volume":"1","author":"Belghiti","year":"2011","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajog.2025.03.015_bib35","doi-asserted-by":"crossref","first-page":"56.e1","DOI":"10.1016\/j.ajog.2010.08.023","article-title":"Oxytocin exposure during labor among women with postpartum hemorrhage secondary to uterine atony","volume":"204","author":"Grotegut","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.03.015_bib36","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00404-022-06901-w","article-title":"Association between duration of intrapartum oxytocin exposure and obstetric hemorrhage","volume":"309","author":"Alexander","year":"2024","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2025.03.015_bib37","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1056\/NEJM199202133260705","article-title":"A controlled trial of a program for the active management of labor","volume":"326","author":"L\u00f3pez-Zeno","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2025.03.015_bib38","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1097\/AOG.0000000000004399","article-title":"High-dose compared with standard-dose oxytocin regimens to augment labor in nulliparous women: a randomized controlled trial","volume":"137","author":"Son","year":"2021","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.03.015_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065612","article-title":"Patterns and outcomes of induction of labour in Africa and Asia: a secondary analysis of the WHO global survey on maternal and neonatal health","volume":"8","author":"Vogel","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2025.03.015_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0297857","article-title":"UK Audit and Research Collaborative in Obstetrics and Gynaecology (UKARCOG) Members. Induction of labour care in the UK: a cross-sectional survey of maternity units","volume":"19","author":"Taylor","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2025.03.015_bib41","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.3109\/14767058.2014.955000","article-title":"Oxytocin discontinuation after the active phase of labor is established","volume":"28","author":"Vlachos","year":"2015","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2025.03.015_bib42","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1097\/AOG.0000000000002325","article-title":"Discontinuing oxytocin infusion in the active phase of labor: a systematic review and meta-analysis","volume":"130","author":"Saccone","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.03.015_bib43","article-title":"Discontinuation of intravenous oxytocin in the active phase of induced labour","volume":"8","author":"Boie","year":"2018","journal-title":"Cochrane Database Syst Rev"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937825001619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937825001619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T03:23:47Z","timestamp":1751599427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937825001619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0002937825001619"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2025.03.015","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced risk of cesarean delivery with oxytocin discontinuation in active labor: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2025.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}